nvs
☆    

India,
2008-02-19 08:11
(6696 d 07:08 ago)

(edited on 2008-02-19 21:46)
Posting: # 1621
Views: 4,263
 

 Type of studies etc. [Dissolution / BCS / IVIVC]

Dear all,
Anybody let me know about flow for in-vitro studies, In which stage of drug designing we have to take approval for in-vitro studies for both innovative & generic drugs.
Which parameters we have to do?
Do we conduct in-vitro studies separately with different mechanism (different in-vitro parameters) for generic & innovative drugs.
What are the common parameters for generic & innovative drugs (in in-vitro studies)
pz share any guidelines regarding this.

--
Edit: Category changed. [Ohlbe]
Edit: Subject line altered. [Helmut]
UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
148 visitors (0 registered, 148 guests [including 26 identified bots]).
Forum time: 16:20 CEST (Europe/Vienna)

I have finally come to the konklusion
that a good reliable set ov bowels
iz worth more to a man
than enny quantity of brains.    Josh Billings

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5